These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22113364)

  • 1. Bioequivalence studies of drugs prescribed mainly for women.
    McGilveray IJ
    J Popul Ther Clin Pharmacol; 2011; 18(3):e516-22. PubMed ID: 22113364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex dependent pharmacokinetics and bioequivalence--time for a change.
    Koren G
    J Popul Ther Clin Pharmacol; 2013; 20(3):e358-61. PubMed ID: 24214491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of drugs in pregnancy.
    Knoppert D
    J Popul Ther Clin Pharmacol; 2011; 18(3):e506-12. PubMed ID: 22113261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs indicated for use during pregnancy.
    Lalonde AB
    J Popul Ther Clin Pharmacol; 2011; 18(3):e513-5. PubMed ID: 22113337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics in pregnancy; clinical significance.
    Koren G
    J Popul Ther Clin Pharmacol; 2011; 18(3):e523-7. PubMed ID: 22113390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences.
    Lu D; Lee SL; Lionberger RA; Choi S; Adams W; Caramenico HN; Chowdhury BA; Conner DP; Katial R; Limb S; Peters JR; Yu L; Seymour S; Li BV
    AAPS J; 2015 May; 17(3):546-57. PubMed ID: 25758352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion of pregnant and breastfeeding women in research - efforts and initiatives.
    Illamola SM; Bucci-Rechtweg C; Costantine MM; Tsilou E; Sherwin CM; Zajicek A
    Br J Clin Pharmacol; 2018 Feb; 84(2):215-222. PubMed ID: 28925019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
    Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic drug interaction studies must consider pharmacological heterogeneity, use of repeated dosing, and translation into a message understandable to practicing clinicians.
    de Leon J; Spina E; Diaz FJ
    J Clin Psychopharmacol; 2009 Jun; 29(3):201-5. PubMed ID: 19440070
    [No Abstract]   [Full Text] [Related]  

  • 10. International Conference on Harmonisation; addendum to International Conference on Harmonisation Guidance on S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2012 May; 77(97):29665-6. PubMed ID: 22616137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation of drug kinetics in pregnancy.
    Pavek P; Ceckova M; Staud F
    Curr Drug Metab; 2009 Jun; 10(5):520-9. PubMed ID: 19689248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of metabolites in bioequivalence.
    Midha KK; Rawson MJ; Hubbard JW
    Pharm Res; 2004 Aug; 21(8):1331-44. PubMed ID: 15359567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bioequivalence of highly variable drugs and drug products.
    Midha KK; Rawson MJ; Hubbard JW
    Int J Clin Pharmacol Ther; 2005 Oct; 43(10):485-98. PubMed ID: 16240706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Global Bioequivalence Harmonization Initiative: Summary report for EUFEPS international conference.
    Chen ML; Blume H; Beuerle G; Davit B; Mehta M; Potthast H; Schug B; Tsang YC; Wedemeyer RS; Weitschies W; Welink J
    Eur J Pharm Sci; 2018 Jan; 111():153-157. PubMed ID: 28964950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Conference on Harmonisation; guidance on S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals intended for Human Use; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Jun; 77(110):33748-9. PubMed ID: 22675782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated drug bioanalysis for human pharmacokinetic studies and therapeutic drug management.
    Huang Y; Shi R; Gee W; Bonderud R
    Bioanalysis; 2012 Aug; 4(15):1919-31. PubMed ID: 22943622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptable and unacceptable procedures in bioavailability and bioequivalence trials.
    Marzo A; Ceppi Monti N
    Pharmacol Res; 1998 Nov; 38(5):401-4. PubMed ID: 9806821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA mulls changes to bioequivalence standards.
    Traynor K
    Am J Health Syst Pharm; 2010 Jun; 67(11):864. PubMed ID: 20484205
    [No Abstract]   [Full Text] [Related]  

  • 19. International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(202):61134-5. PubMed ID: 16237860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Jul; 66(135):36791-2. PubMed ID: 12356097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.